Active 0 6 0 6 O
, 6 7 6 7 O
uncontrolled 8 20 8 20 O
bacterial 21 30 21 30 B-chronic_disease
, 30 31 30 31 O
viral 32 37 32 37 O
, 37 38 37 38 O
or 39 41 39 41 O
fungal 42 48 42 48 B-chronic_disease
infections 49 59 49 59 I-chronic_disease
, 59 60 59 60 O
requiring 61 70 61 70 O
systemic 71 79 71 79 B-treatment
therapy 80 87 80 87 I-treatment

Any 0 3 88 91 O
condition 4 13 92 101 O
that 14 18 102 106 O
prevents 19 27 107 115 O
compliance 28 38 116 126 O
with 39 43 127 131 O
the 44 47 132 135 O
protocol 48 56 136 144 O
or 57 59 145 147 O
adherence 60 69 148 157 O
to 70 72 158 160 O
therapy 73 80 161 168 B-treatment

Females 0 7 169 176 B-gender
who 8 11 177 180 O
are 12 15 181 184 O
pregnant 16 24 185 193 B-pregnancy
or 25 27 194 196 O
lactating 28 37 197 206 O
or 38 40 207 209 O
plan 41 45 210 214 B-pregnancy
to 46 48 215 217 I-pregnancy
become 49 55 218 224 I-pregnancy
pregnant 56 64 225 233 I-pregnancy
during 65 71 234 240 O
the 72 75 241 244 O
course 76 82 245 251 O
of 83 85 252 254 O
this 86 90 255 259 O
study 91 96 260 265 O

Fever 0 5 266 271 B-clinical_variable
( 6 7 272 273 O
> 7 8 273 274 O
38.1 9 13 275 279 B-lower_bound
° 13 14 279 280 I-lower_bound
C 14 15 280 281 I-lower_bound
) 15 16 281 282 O

Glioblastoma 0 12 283 295 B-cancer
or 13 15 296 298 O
gliosarcoma 16 27 299 310 B-cancer
disease 28 35 311 318 O
with 36 40 319 323 O
leptomeningeal 41 55 324 338 B-cancer
spread 56 62 339 345 O

Had 0 3 346 349 O
prior 4 9 350 355 O
exposure 10 18 356 364 O
to 19 21 365 367 O
gene 22 26 368 372 O
vector 27 33 373 379 O
delivery 34 42 380 388 O
products 43 51 389 397 O
within 52 58 398 404 O
6 59 60 405 406 B-upper_bound
months 61 67 407 413 I-upper_bound

Have 0 4 414 418 O
a 5 6 419 420 O
history 7 14 421 428 O
of 15 17 429 431 O
hypersensitivity 18 34 432 448 O
reaction 35 43 449 457 O
to 44 46 458 460 O
any 47 50 461 464 O
of 51 53 465 467 O
the 54 57 468 471 O
components 58 68 472 482 O
of 69 71 483 485 O
Temozolomide 72 84 486 498 B-allergy_name

Have 0 4 499 503 O
a 5 6 504 505 O
history 7 14 506 513 O
of 15 17 514 516 O
hypersensitivity 18 34 517 533 O
to 35 37 534 536 O
dacarbazine 38 49 537 548 B-allergy_name
( 50 51 549 550 I-allergy_name
DTIC 51 55 550 554 I-allergy_name
) 55 56 554 555 I-allergy_name

Have 0 4 556 560 O
diastolic 5 14 561 570 B-clinical_variable
blood 15 20 571 576 I-clinical_variable
pressure 21 29 577 585 I-clinical_variable
of 30 32 586 588 O
> 33 34 589 590 O
90 35 37 591 593 B-lower_bound
mm 38 40 594 596 I-lower_bound
Hg 41 43 597 599 I-lower_bound
resting 44 51 600 607 O
at 52 54 608 610 O
baseline 55 63 611 619 O
despite 64 71 620 627 O
medication 72 82 628 638 B-treatment

Have 0 4 639 643 O
recovered 5 14 644 653 O
from 15 19 654 658 O
any 20 23 659 662 O
previous 24 32 663 671 O
therapy 33 40 672 679 B-treatment
side 41 45 680 684 O
effects 46 53 685 692 O
or 54 56 693 695 O
toxicities 57 67 696 706 O

Histologically 0 14 707 721 O
confirmed 15 24 722 731 O
glioblastoma 25 37 732 744 B-cancer
or 38 40 745 747 O
gliosarcoma 41 52 748 759 B-cancer
in 53 55 760 762 O
1st 56 59 763 766 O
, 59 60 766 767 O
2nd 61 64 768 771 O
or 65 67 772 774 O
3rd 68 71 775 778 O
relapse 72 79 779 786 O

Histology 0 9 787 796 O
other 10 15 797 802 O
than 16 20 803 807 O
astrocytoma 21 32 808 819 B-cancer
grade 33 38 820 825 I-cancer
IV 39 41 826 828 I-cancer

Karnofsky 0 9 829 838 B-clinical_variable
performance 10 21 839 850 I-clinical_variable
status 22 28 851 857 I-clinical_variable
≥ 29 30 858 859 O
60 31 33 860 862 B-lower_bound
% 33 34 862 863 I-lower_bound

Male 0 4 864 868 B-gender

Males 0 5 869 874 B-gender
not 6 9 875 878 O
naturally 10 19 879 888 O
or 20 22 889 891 O
surgically 23 33 892 902 O
sterile 34 41 903 910 O
, 41 42 910 911 O
who 43 46 912 915 O
have 47 51 916 920 O
a 52 53 921 922 O
female 54 60 923 929 B-gender
partner 61 68 930 937 I-gender
of 69 71 938 940 O
childbearing 72 84 941 953 O
potential 85 94 954 963 O
, 94 95 963 964 O
must 96 100 965 969 O
agree 101 106 970 975 B-contraception_consent
to 107 109 976 978 I-contraception_consent
use 110 113 979 982 I-contraception_consent
two 114 117 983 986 I-contraception_consent
reliable 118 126 987 995 I-contraception_consent
methods 127 134 996 1003 I-contraception_consent
of 135 137 1004 1006 I-contraception_consent
contraception 138 151 1007 1020 I-contraception_consent
from 152 156 1021 1025 O
screening 157 166 1026 1035 O
and 167 170 1036 1039 O
up 171 173 1040 1042 O
to 174 176 1043 1045 O
30 177 179 1046 1048 B-upper_bound
days 180 184 1049 1053 I-upper_bound
after 185 190 1054 1059 I-upper_bound
discontinuation 191 206 1060 1075 O
of 207 209 1076 1078 O
study 210 215 1079 1084 O
treatment 216 225 1085 1094 B-treatment

Measurable 0 10 1095 1105 O
disease 11 18 1106 1113 O
on 19 21 1114 1116 O
MRI 22 25 1117 1120 B-treatment
performed 26 35 1121 1130 O
within 36 42 1131 1137 O
14 43 45 1138 1140 B-upper_bound
days 46 50 1141 1145 I-upper_bound
prior 51 56 1146 1151 I-upper_bound
to 57 59 1152 1154 O
registration 60 72 1155 1167 O

Moderate 0 8 1168 1176 O
to 9 11 1177 1179 O
severe 12 18 1180 1186 B-chronic_disease
hepatic 19 26 1187 1194 I-chronic_disease
impairment 27 37 1195 1205 I-chronic_disease

Organ 0 5 1206 1211 B-clinical_variable
function 6 14 1212 1220 I-clinical_variable
characterized 15 28 1221 1234 O
by 29 31 1235 1237 O
≤ 32 33 1238 1239 O
Grade 34 39 1240 1245 B-upper_bound
1 40 41 1246 1247 I-upper_bound

PT 0 2 1248 1250 B-clinical_variable
and 3 6 1251 1254 O
PTT 7 10 1255 1258 B-clinical_variable
≤ 11 12 1259 1260 O
1.5 13 16 1261 1264 B-upper_bound
X 17 18 1265 1266 I-upper_bound
ULN 19 22 1267 1270 I-upper_bound

Patients 0 8 1271 1279 O
must 9 13 1280 1284 O
be 14 16 1285 1287 O
willing 17 24 1288 1295 O
to 25 27 1296 1298 O
forego 28 34 1299 1305 O
other 35 40 1306 1311 O
cytotoxic 41 50 1312 1321 B-treatment
and 51 54 1322 1325 O
non 55 58 1326 1329 B-treatment
- 58 59 1329 1330 I-treatment
cytotoxic 59 68 1330 1339 I-treatment
drug 69 73 1340 1344 I-treatment
or 74 76 1345 1347 O
radiation 77 86 1348 1357 B-treatment
therapy 87 94 1358 1365 I-treatment
against 95 102 1366 1373 O
the 103 106 1374 1377 O
tumor 107 112 1378 1383 B-cancer
while 113 118 1384 1389 O
enrolled 119 127 1390 1398 O
in 128 130 1399 1401 O
the 131 134 1402 1405 O
study 135 140 1406 1411 O

Patients 0 8 1412 1420 O
who 9 12 1421 1424 O
are 13 16 1425 1428 O
currently 17 26 1429 1438 O
taking 27 33 1439 1445 O
Coumadin 34 42 1446 1454 B-treatment
or 43 45 1455 1457 O
Coumadin 46 54 1458 1466 B-treatment
derivatives 55 66 1467 1478 I-treatment
other 67 72 1479 1484 O
than 73 77 1485 1489 O
to 78 80 1490 1492 O
maintain 81 89 1493 1501 O
patency 90 97 1502 1509 O
of 98 100 1510 1512 O
venous 101 107 1513 1519 O
access 108 114 1520 1526 O
lines 115 120 1527 1532 O

Patients 0 8 1533 1541 O
with 9 13 1542 1546 O
a 14 15 1547 1548 O
history 16 23 1549 1556 O
of 24 26 1557 1559 O
any 27 30 1560 1563 O
other 31 36 1564 1569 O
cancer 37 43 1570 1576 B-cancer
, 43 44 1576 1577 O
unless 45 51 1578 1584 O
in 52 54 1585 1587 O
complete 55 63 1588 1596 O
remission 64 73 1597 1606 O
, 73 74 1606 1607 O
and 75 78 1608 1611 O
off 79 82 1612 1615 O
all 83 86 1616 1619 O
therapy 87 94 1620 1627 B-treatment
for 95 98 1628 1631 O
that 99 103 1632 1636 O
disease 104 111 1637 1644 O
for 112 115 1645 1648 O
a 116 117 1649 1650 O
minimum 118 125 1651 1658 O
of 126 128 1659 1661 O
5 129 130 1662 1663 B-lower_bound
years 131 136 1664 1669 I-lower_bound

Patients 0 8 1670 1678 O
with 9 13 1679 1683 O
serum 14 19 1684 1689 B-clinical_variable
aspartate 20 29 1690 1699 I-clinical_variable
aminotransferase 30 46 1700 1716 I-clinical_variable
, 46 47 1716 1717 O
alanine 48 55 1718 1725 B-clinical_variable
aminotransferase 56 72 1726 1742 I-clinical_variable
> 73 74 1743 1744 O
2.5 75 78 1745 1748 B-lower_bound
X 79 80 1749 1750 I-lower_bound
the 81 84 1751 1754 I-lower_bound
upper 85 90 1755 1760 I-lower_bound
limit 91 96 1761 1766 I-lower_bound
of 97 99 1767 1769 I-lower_bound
normal 100 106 1770 1776 I-lower_bound
( 107 108 1777 1778 I-lower_bound
ULN 108 111 1778 1781 I-lower_bound
) 111 112 1781 1782 I-lower_bound
and 113 116 1783 1786 O
bilirubin 117 126 1787 1796 B-clinical_variable
> 127 128 1797 1798 O
1.5 128 131 1798 1801 B-lower_bound
ULN 132 135 1802 1805 I-lower_bound

Planned 0 7 1806 1813 B-treatment
treatment 8 17 1814 1823 I-treatment
, 17 18 1823 1824 O
or 19 21 1825 1827 O
treatment 22 31 1828 1837 O
with 32 36 1838 1842 O
any 37 40 1843 1846 O
investigational 41 56 1847 1862 B-treatment
drug 57 61 1863 1867 I-treatment
within 62 68 1868 1874 O
4 69 70 1875 1876 B-upper_bound
weeks 71 76 1877 1882 I-upper_bound
prior 77 82 1883 1888 I-upper_bound
to 83 85 1889 1891 O
screening 86 95 1892 1901 O

Positive 0 8 1902 1910 O
results 9 16 1911 1918 O
from 17 21 1919 1923 O
HIV 22 25 1924 1927 B-chronic_disease
serology 26 34 1928 1936 O
testing 35 42 1937 1944 O
, 42 43 1944 1945 O
if 44 46 1946 1948 O
any 47 50 1949 1952 O
available 51 60 1953 1962 O

Prior 0 5 1963 1968 B-treatment
chemotherapy 6 18 1969 1981 I-treatment
for 19 22 1982 1985 O
recurrent 23 32 1986 1995 O
GBM 33 36 1996 1999 B-cancer
with 37 41 2000 2004 O
nitrosourea 42 53 2005 2016 B-treatment
compounds 54 63 2017 2026 I-treatment
including 64 73 2027 2036 O
Gliadel 74 81 2037 2044 B-treatment
® 81 82 2044 2045 I-treatment
wafers 83 89 2046 2052 I-treatment
or 90 92 2053 2055 O
bevacizumab 93 104 2056 2067 B-treatment

Prior 0 5 2068 2073 B-treatment
focal 6 11 2074 2079 I-treatment
radiotherapy 12 24 2080 2092 I-treatment
within 25 31 2093 2099 O
3 32 33 2100 2101 B-upper_bound
months 34 40 2102 2108 I-upper_bound
of 41 43 2109 2111 O
screening 44 53 2112 2121 O

Radiographic 0 12 2122 2134 O
demonstration 13 26 2135 2148 O
of 27 29 2149 2151 O
disease 30 37 2152 2159 O
progression 38 49 2160 2171 O
following 50 59 2172 2181 O
prior 60 65 2182 2187 B-treatment
therapy 66 73 2188 2195 I-treatment

Receiving 0 9 2196 2205 O
hematopoietic 10 23 2206 2219 B-treatment
growth 24 30 2220 2226 I-treatment
factors 31 38 2227 2234 I-treatment

Renal 0 5 2235 2240 B-clinical_variable
insufficiency 6 19 2241 2254 I-clinical_variable
or 20 22 2255 2257 I-clinical_variable
serum 23 28 2258 2263 I-clinical_variable
creatinine 29 39 2264 2274 I-clinical_variable
> 40 41 2275 2276 O
1.5 41 44 2276 2279 B-lower_bound
X 45 46 2280 2281 I-lower_bound
ULN 47 50 2282 2285 I-lower_bound
at 51 53 2286 2288 O
screening 54 63 2289 2298 O

Requiring 0 9 2299 2308 O
renal 10 15 2309 2314 B-treatment
dialysis 16 24 2315 2323 I-treatment

Serious 0 7 2324 2331 O
nonmalignant 8 20 2332 2344 B-chronic_disease
disease 21 28 2345 2352 I-chronic_disease

Substance 0 9 2353 2362 O
or 10 12 2363 2365 O
alcohol 13 20 2366 2373 O
abuse 21 26 2374 2379 O
or 27 29 2380 2382 O
dependence 30 40 2383 2393 O
, 40 41 2393 2394 O
within 42 48 2395 2401 O
12 49 51 2402 2404 B-upper_bound
months 52 58 2405 2411 I-upper_bound
prior 59 64 2412 2417 I-upper_bound
to 65 67 2418 2420 O
screening 68 77 2421 2430 O

Supine 0 6 2431 2437 B-clinical_variable
systolic 7 15 2438 2446 I-clinical_variable
blood 16 21 2447 2452 I-clinical_variable
pressure 22 30 2453 2461 I-clinical_variable
< 31 32 2462 2463 O
100 33 36 2464 2467 B-upper_bound
mmHg 37 41 2468 2472 I-upper_bound
or 42 44 2473 2475 O
supine 45 51 2476 2482 B-clinical_variable
diastolic 52 61 2483 2492 I-clinical_variable
blood 62 67 2493 2498 I-clinical_variable
pressure 68 76 2499 2507 I-clinical_variable
< 77 78 2508 2509 O
50 79 81 2510 2512 B-upper_bound
mmHg 82 86 2513 2517 I-upper_bound
at 87 89 2518 2520 O
screening 90 99 2521 2530 O
and 100 103 2531 2534 O
baseline 104 112 2535 2543 O

Treated 0 7 2544 2551 O
with 8 12 2552 2556 O
antibiotics 13 24 2557 2568 B-treatment
for 25 28 2569 2572 O
infection 29 38 2573 2582 B-chronic_disease
within 39 45 2583 2589 O
one 46 49 2590 2593 B-upper_bound
week 50 54 2594 2598 I-upper_bound
prior 55 60 2599 2604 I-upper_bound
to 61 63 2605 2607 O
study 64 69 2608 2613 O
entry 70 75 2614 2619 O

Tumor 0 5 2620 2625 B-cancer
foci 6 10 2626 2630 O
detected 11 19 2631 2639 O
below 20 25 2640 2645 O
the 26 29 2646 2649 O
tentorium 30 39 2650 2659 O
or 40 42 2660 2662 O
beyond 43 49 2663 2669 O
the 50 53 2670 2673 O
cranial 54 61 2674 2681 O
vault 62 67 2682 2687 O

Urinalysis 0 10 2688 2698 B-treatment
: 10 11 2698 2699 O
No 12 14 2700 2702 O
clinically 15 25 2703 2713 O
significant 26 37 2714 2725 O
abnormalities 38 51 2726 2739 O

Women 0 5 2740 2745 B-gender
of 6 8 2746 2748 O
childbearing 9 21 2749 2761 O
potential 22 31 2762 2771 O
must 32 36 2772 2776 O
agree 37 42 2777 2782 B-contraception_consent
to 43 45 2783 2785 I-contraception_consent
use 46 49 2786 2789 I-contraception_consent
two 50 53 2790 2793 I-contraception_consent
reliable 54 62 2794 2802 I-contraception_consent
methods 63 70 2803 2810 I-contraception_consent
of 71 73 2811 2813 I-contraception_consent
contraception 74 87 2814 2827 I-contraception_consent
from 88 92 2828 2832 O
screening 93 102 2833 2842 O
and 103 106 2843 2846 O
up 107 109 2847 2849 O
to 110 112 2850 2852 O
30 113 115 2853 2855 B-upper_bound
days 116 120 2856 2860 I-upper_bound
after 121 126 2861 2866 O
discontinuation 127 142 2867 2882 O
of 143 145 2883 2885 O
study 146 151 2886 2891 B-treatment
treatment 152 161 2892 2901 I-treatment

Women 0 5 2902 2907 B-gender
of 6 8 2908 2910 O
childbearing 9 21 2911 2923 O
potential 22 31 2924 2933 O
must 32 36 2934 2938 O
have 37 41 2939 2943 O
a 42 43 2944 2945 O
negative 44 52 2946 2954 B-pregnancy
serum 53 58 2955 2960 I-pregnancy
beta 59 63 2961 2965 I-pregnancy
- 63 64 2965 2966 I-pregnancy
HCG 64 67 2966 2969 I-pregnancy
pregnancy 68 77 2970 2979 I-pregnancy
test 78 82 2980 2984 O
documented 83 93 2985 2995 O
within 94 100 2996 3002 O
3 101 102 3003 3004 B-upper_bound
days 103 107 3005 3009 I-upper_bound
prior 108 113 3010 3015 I-upper_bound
to 114 116 3016 3018 O
study 117 122 3019 3024 O
initiation 123 133 3025 3035 O

female 0 6 3036 3042 B-gender
patients 7 15 3043 3051 I-gender

≥ 0 1 3052 3053 O
18 2 4 3054 3056 B-lower_bound
years 5 10 3057 3062 I-lower_bound
of 11 13 3063 3065 O
age 14 17 3066 3069 B-age

